
|Videos|January 13, 2015
How New Agents are Helping Address Clostridium Difficile-Associated Diarrhea Concerns
J. Russell May, PharmD, FASHP, clinical professor at Georgia Regents University College of Pharmacy, discusses how new agents are helping address Clostridium difficile-associated diarrhea concerns.
Advertisement
J. Russell May, PharmD, FASHP, clinical professor at Georgia Regents University College of Pharmacy, discusses how new agents are helping address Clostridium difficile-associated diarrhea concerns.
This interview was recorded at the ASHP 2014 Midyear Clinical Meeting in Anaheim, California.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Breaking News: AstraZeneca, White House Announce Most-Favored-Nation Deal
2
New Report Details Rising Incidence of Invasive Lobular Carcinoma
3
Tramadol and Antidepressants Linked to Increased Seizure Risk in Older Adults
4
FDA Approves Expanded Indication for Risperidone Extended-Release Injectable to Treat Bipolar I Disorder
5